REPL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 20.60%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $1,731,374.03

Replimune Group Insider Trading History Chart

Replimune Group Share Price & Price History

^$8.52

▼ -0.19 (-2.18%)

As of 06/27/2024 01:00 AM ET

Days: 30 | 90 | 365

Musk’s new company could top a trillion?

From Paradigm Press | Ad

The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840.

Click here to see the details because there’s not much time to prepare.

Replimune Group Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/7/2024	Konstantinos Xynos	Insider	Sell	15,881	$7.50	$119,107.50	117,131
5/16/2024	Andrew Schwendenman	CAO	Sell	2,298	$6.47	$14,868.06	38,238
5/16/2024	Christopher Sarchi	Insider	Sell	2,218	$6.47	$14,350.46	92,252
5/16/2024	Colin A. Love	COO	Sell	17,615	$6.47	$113,969.05	777,345
5/16/2024	Philip Astley-Sparke	Chairman	Sell	37,928	$6.47	$245,394.16	1,487,350
5/16/2024	Robert Coffin	Director	Sell	11,464	$6.47	$74,172.08	1,821,872
5/16/2024	Sushil Patel	CEO	Sell	20,194	$6.47	$130,655.18	212,014
11/16/2023	Konstantinos Xynos	Insider	Sell	7,313	$10.92	$79,857.96	112,714
9/11/2023	Pamela Esposito	Insider	Sell	5,358	$20.01	$107,213.58	263,436
8/22/2023	Pamela Esposito	Insider	Sell	18,600	$20.01	$372,186.00	263,436
8/11/2023	Pamela Esposito	Insider	Sell	1,400	$20.00	$28,000.00	263,436
7/10/2023	Pamela Esposito	Insider	Sell	20,000	$21.58	$431,600.00	263,436
6/13/2023	Tanya Lewis	Insider	Sell	12,860	$24.06	$309,411.60	135,293
5/16/2023	Colin A. Love	COO	Sell	10,775	$18.05	$194,488.75	794,960
5/16/2023	Jean M Franchi	CFO	Sell	11,351	$18.05	$204,885.55	128,748
5/16/2023	Philip Astley-Sparke	CEO	Sell	17,902	$18.05	$323,131.10	1,525,278
5/16/2023	Sushil Patel	Insider	Sell	15,575	$18.05	$281,128.75	154,571
12/9/2022	Pamela Esposito	Insider	Sell	15,000	$25.03	$375,450.00	229,402
5/16/2022	Colin A. Love	COO	Sell	6,324	$14.59	$92,267.16	765,735
5/16/2022	Jean M Franchi	CFO	Sell	3,436	$14.59	$50,131.24	95,099
5/16/2022	Pamela Esposito	Insider	Sell	3,507	$14.59	$51,167.13	229,402
5/16/2022	Philip Astley-Sparke	CEO	Sell	9,632	$14.59	$140,530.88	1,401,080
3/14/2022	Fund Iv L.P. Omega	Major Shareholder	Sell	16,500	$15.42	$254,430.00
11/22/2021	Fund Iv L.P. Omega	Director	Sell	10,162	$34.70	$352,621.40
11/18/2021	Fund Iv L.P. Omega	Director	Sell	2,441	$33.50	$81,773.50
11/15/2021	Fund Iv L.P. Omega	Director	Sell	782	$33.66	$26,322.12
11/12/2021	Fund Iv L.P. Omega	Director	Sell	23,235	$33.66	$782,090.10
11/10/2021	Fund Iv L.P. Omega	Director	Sell	11	$33.50	$368.50
11/8/2021	Fund Iv L.P. Omega	Director	Sell	3,817	$33.53	$127,984.01
11/4/2021	Fund Iv L.P. Omega	Director	Sell	25,225	$33.58	$847,055.50
10/18/2021	Colin A. Love	COO	Sell	12,711	$29.58	$375,991.38
10/15/2021	Colin A. Love	COO	Sell	17,289	$30.42	$525,931.38
9/23/2021	Fund Iv L.P. Omega	Director	Sell	12,171	$33.58	$408,702.18
9/16/2021	Fund Iv L.P. Omega	Director	Sell	5,537	$32.55	$180,229.35
9/15/2021	Colin A. Love	COO	Sell	30,000	$31.23	$936,900.00
8/16/2021	Colin A. Love	COO	Sell	30,000	$29.93	$897,900.00	808,509
8/5/2021	Pamela Esposito	Insider	Sell	25,800	$35.09	$905,322.00	214,359
7/21/2021	Pamela Esposito	Insider	Sell	12,538	$33.17	$415,885.46	215,021
7/15/2021	Colin A. Love	COO	Sell	30,000	$32.02	$960,600.00
7/15/2021	Pamela Esposito	Insider	Sell	4,600	$33.37	$153,502.00
7/2/2021	Robert Coffin	Insider	Sell	7,810	$40.04	$312,712.40
6/28/2021	Robert Coffin	Insider	Sell	14,663	$40.04	$587,106.52	1,806,320

Jeff Bezos & 48 Members of Congress Are Buying ONE Sector…

From InvestorPlace | Ad

Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…

Click here for the details

SEC Filings (Institutional Ownership Changes) for Replimune Group (NASDAQ:REPL)

92.53% of Replimune Group stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Replimune Group Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/16/2024	California State Teachers Retirement System	36,820	$0.30M	0.0%	-7.2%	0.060%
5/16/2024	Jacobs Levy Equity Management Inc.	133,195	$1.09M	0.0%	N/A	0.217%
5/16/2024	Redmile Group LLC	3,729,983	$30.47M	1.1%	-3.5%	6.076%
5/15/2024	Price T Rowe Associates Inc. MD	6,548,930	$53.51M	0.0%	+12.0%	10.668%
5/14/2024	Nan Fung Group Holdings Ltd	204,939	$1.67M	1.6%	+10.9%	0.334%
5/14/2024	EntryPoint Capital LLC	17,704	$0.15M	0.1%	-40.7%	0.029%
5/13/2024	Clearbridge Investments LLC	277,969	$2.27M	0.0%	+2.7%	0.453%
5/10/2024	Acadian Asset Management LLC	113,649	$0.93M	0.0%	N/A	0.185%
5/10/2024	Vanguard Group Inc.	2,770,328	$22.63M	0.0%	+1.2%	4.513%
5/8/2024	Entropy Technologies LP	59,326	$0.49M	0.1%	+18.3%	0.097%
5/8/2024	Russell Investments Group Ltd.	17,111	$0.14M	0.0%	N/A	0.028%
5/7/2024	SG Americas Securities LLC	17,968	$0.15M	0.0%	N/A	0.029%
5/1/2024	BNP Paribas Financial Markets	58,725	$0.48M	0.0%	-70.1%	0.096%
4/29/2024	Principal Financial Group Inc.	13,129	$0.11M	0.0%	-10.7%	0.021%
4/29/2024	China Universal Asset Management Co. Ltd.	11,808	$96K	0.0%	+72.8%	0.019%
4/19/2024	Denali Advisors LLC	36,300	$0.30M	0.1%	N/A	0.059%
4/18/2024	Diversified Trust Co	11,460	$94K	0.0%	N/A	0.019%
4/5/2024	Los Angeles Capital Management LLC	66,405	$0.54M	0.0%	+83.4%	0.108%
3/7/2024	Fcpm Iii Services B.V.	4,866,499	$41.02M	12.2%	N/A	7.927%
3/5/2024	Fisher Asset Management LLC	77,663	$0.66M	0.0%	+37.7%	0.127%
3/5/2024	Wellington Management Group LLP	246,624	$2.08M	0.0%	-5.6%	0.402%
3/1/2024	Goldman Sachs Group Inc.	2,238,883	$18.87M	0.0%	+300.3%	3.647%
2/14/2024	Pennant Investors LP	30,500	$0.26M	0.1%	N/A	0.050%
2/14/2024	Sectoral Asset Management Inc.	305,412	$2.58M	1.1%	+12.7%	0.497%
2/13/2024	Tower Research Capital LLC TRC	4,207	$35K	0.0%	+236.8%	0.007%
2/13/2024	Rafferty Asset Management LLC	463,397	$3.91M	0.0%	+148.1%	0.755%
2/9/2024	Quest Partners LLC	9,002	$76K	0.0%	N/A	0.015%
2/9/2024	Clearbridge Investments LLC	270,695	$2.28M	0.0%	N/A	0.458%
2/7/2024	BNP Paribas Financial Markets	196,251	$1.65M	0.0%	+517.9%	0.332%
2/7/2024	E Fund Management Co. Ltd.	24,739	$0.21M	0.0%	N/A	0.042%
2/6/2024	Los Angeles Capital Management LLC	36,202	$0.31M	0.0%	N/A	0.061%
2/6/2024	Swiss National Bank	69,800	$0.59M	0.0%	-8.5%	0.118%
2/6/2024	Fisher Asset Management LLC	77,663	$0.66M	0.0%	+37.7%	0.131%
2/1/2024	New York State Common Retirement Fund	7,393	$62K	0.0%	-55.0%	0.013%
2/1/2024	Handelsbanken Fonder AB	12,000	$0.10M	0.0%	N/A	0.020%
1/30/2024	Cornercap Investment Counsel Inc.	26,493	$0.22M	0.0%	N/A	0.045%
1/30/2024	Vontobel Holding Ltd.	305,412	$2.58M	0.0%	N/A	0.517%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	40,223	$0.34M	0.0%	+32.5%	0.068%
1/24/2024	China Universal Asset Management Co. Ltd.	6,833	$58K	0.0%	+352.8%	0.012%
1/8/2024	Harbor Capital Advisors Inc.	32,311	$0.27M	0.1%	+6.1%	0.055%
1/5/2024	Exchange Traded Concepts LLC	7,837	$66K	0.0%	+34.0%	0.013%
12/18/2023	Vanguard Group Inc.	2,596,119	$44.42M	0.0%	+10.3%	4.396%
12/1/2023	Wellington Management Group LLP	261,277	$4.47M	0.0%	+25.2%	0.442%
11/22/2023	Graham Capital Management L.P.	19,867	$0.34M	0.0%	N/A	0.034%
11/15/2023	Redmile Group LLC	4,163,922	$71.25M	3.4%	-5.8%	7.050%
11/15/2023	Sectoral Asset Management Inc.	271,056	$4.64M	0.9%	+13.6%	0.459%
11/15/2023	Alps Advisors Inc.	43,550	$0.75M	0.0%	+2.6%	0.074%
11/14/2023	Profund Advisors LLC	31,557	$0.54M	0.0%	+19.0%	0.053%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	82,476	$1.41M	0.0%	-8.1%	0.140%
11/13/2023	Algert Global LLC	84,682	$1.45M	0.1%	-35.3%	0.143%
11/13/2023	Hsbc Holdings PLC	19,718	$0.33M	0.0%	+45.3%	0.033%
11/13/2023	FMR LLC	1,268,683	$21.71M	0.0%	-17.9%	2.148%
11/13/2023	Rafferty Asset Management LLC	186,801	$3.20M	0.0%	+29.1%	0.316%
11/13/2023	Lord Abbett & CO. LLC	184,419	$3.16M	0.0%	-82.2%	0.312%
11/9/2023	Loomis Sayles & Co. L P	1,290,450	$22.08M	0.0%	+8.7%	2.187%
11/9/2023	Citigroup Inc.	79,527	$1.36M	0.0%	+48.7%	0.135%
11/9/2023	Skandinaviska Enskilda Banken AB publ	9,900	$0.17M	0.0%	-68.9%	0.017%
11/8/2023	Charles Schwab Investment Management Inc.	378,310	$6.47M	0.0%	+32.8%	0.641%
11/8/2023	Swiss National Bank	76,300	$1.31M	0.0%	-4.9%	0.129%
11/7/2023	Barclays PLC	118,412	$2.03M	0.0%	+4.8%	0.201%
11/2/2023	Principal Financial Group Inc.	14,748	$0.25M	0.0%	+17.2%	0.025%
10/31/2023	China Universal Asset Management Co. Ltd.	1,509	$26K	0.0%	+99.3%	0.003%
10/27/2023	TD Asset Management Inc	267,646	$4.58M	0.0%	+100.0%	0.454%
10/27/2023	Emerald Mutual Fund Advisers Trust	874,210	$14.96M	0.9%	-3.0%	1.482%
10/26/2023	Emerald Advisers LLC	1,052,524	$18.01M	0.9%	-3.1%	1.784%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	30,364	$0.52M	0.0%	+3.9%	0.051%
10/24/2023	Bank of New York Mellon Corp	167,431	$2.87M	0.0%	-0.5%	0.284%
10/20/2023	Harbor Capital Advisors Inc.	30,467	$0.52M	0.1%	+18.2%	0.052%
8/15/2023	Braidwell LP	487,520	$11.32M	0.4%	+561.8%	0.826%
8/15/2023	Camber Capital Management LP	1,550,000	$35.99M	1.2%	+24.0%	2.627%
8/14/2023	Osterweis Capital Management Inc.	117,855	$2.74M	0.2%	-21.9%	0.200%
8/14/2023	Marshall Wace LLP	1,233,224	$28.64M	0.1%	+90.6%	2.090%
8/14/2023	Caption Management LLC	32,968	$0.77M	0.0%	N/A	0.056%
8/14/2023	Omega Fund Management LLC	3,001,319	$69.69M	39.0%	-1.6%	5.087%
8/11/2023	Nan Fung Group Holdings Ltd	184,739	$4.29M	2.7%	-2.4%	0.313%
8/11/2023	Panagora Asset Management Inc.	58,268	$1.35M	0.0%	-14.2%	0.099%
8/11/2023	Sectoral Asset Management Inc.	238,541	$5.54M	0.9%	-9.0%	0.404%
8/11/2023	Schroder Investment Management Group	337,662	$7.84M	0.0%	-20.5%	0.572%
8/11/2023	Trexquant Investment LP	25,298	$0.59M	0.0%	-73.2%	0.043%
8/11/2023	ExodusPoint Capital Management LP	152,138	$3.53M	0.0%	+22.5%	0.258%
8/10/2023	ProShare Advisors LLC	9,037	$0.21M	0.0%	N/A	0.015%
8/10/2023	Profund Advisors LLC	26,512	$0.62M	0.0%	-34.2%	0.045%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	29,226	$0.68M	0.0%	+6.0%	0.050%
8/10/2023	US Bancorp DE	19,877	$0.46M	0.0%	+9.8%	0.034%
8/10/2023	Citigroup Inc.	53,468	$1.24M	0.0%	-69.3%	0.091%
8/9/2023	Dimensional Fund Advisors LP	1,284,449	$29.83M	0.0%	+19.3%	2.177%
8/9/2023	BNP Paribas Arbitrage SNC	30,500	$0.71M	0.0%	-67.9%	0.052%
8/9/2023	TD Asset Management Inc	133,823	$3.11M	0.0%	-7.4%	0.227%
8/9/2023	Swiss National Bank	80,200	$1.86M	0.0%	+3.8%	0.136%
8/8/2023	Fisher Asset Management LLC	56,396	$1.31M	0.0%	-19.5%	0.096%
8/8/2023	Rhumbline Advisers	69,605	$1.62M	0.0%	-5.2%	0.118%
8/8/2023	Candriam S.C.A.	612,193	$14.22M	0.1%	-7.7%	1.038%
8/4/2023	American International Group Inc.	19,607	$0.46M	0.0%	-13.0%	0.033%
8/3/2023	Barclays PLC	113,011	$2.62M	0.0%	+23.5%	0.192%
8/3/2023	Bank of New York Mellon Corp	168,236	$3.91M	0.0%	-3.0%	0.285%
7/28/2023	Moody Aldrich Partners LLC	106,808	$2.48M	0.5%	+21.1%	0.185%
7/24/2023	Allspring Global Investments Holdings LLC	3,030	$70K	0.0%	-15.9%	0.005%
7/20/2023	Exchange Traded Concepts LLC	5,898	$0.14M	0.0%	N/A	0.010%
7/19/2023	Teacher Retirement System of Texas	9,987	$0.23M	0.0%	-9.5%	0.017%
7/18/2023	Allspring Global Investments Holdings LLC	3,030	$70K	0.0%	-15.9%	0.005%

Data available starting January 2016

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company's proprietary tumor-directed oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF, which is in Phase I/II clinical trials for a range of solid tumors; and that has completed Phase II clinical trials for treating cutaneous squamous cell carcinoma. The company is also developing RP2, which is in Phase I clinical trials to express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trial to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.

Today's Range

Now: $8.52

$8.33

$8.79

50 Day Range

MA: $6.84

$5.01

$9.46

52 Week Range

Now: $8.52

$4.92

$24.28

Volume

523,233 shs

Average Volume

2,085,769 shs

Market Capitalization

$523.30 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.15

Who are the company insiders with the largest holdings of Replimune Group?: Replimune Group's top insider shareholders include:
Robert Coffin (Director)
Philip Astley-Sparke (CEO)
Philip Astley-Sparke (Chairman)
Colin Love (COO)
Pamela Esposito (Insider)
Sushil Patel (CEO)
Sushil Patel (Insider)
Tanya Lewis (Insider)
Jean M Franchi (CFO)
Konstantinos Xynos (Insider)
Christopher Sarchi (Insider)
Andrew Schwendenman (CAO)
Learn More about top insider investors at Replimune Group.
Who are the major institutional investors of Replimune Group?: Replimune Group's top institutional shareholders include:
Price T Rowe Associates Inc. MD — 10.67%
Redmile Group LLC — 6.08%
Vanguard Group Inc. — 4.51%
Clearbridge Investments LLC — 0.45%
Nan Fung Group Holdings Ltd — 0.33%
Jacobs Levy Equity Management Inc. — 0.22%
Learn More about top institutional investors of Replimune Group stock.
Which institutional investors are selling Replimune Group stock?: Within the last quarter, REPL stock was sold by these institutional investors:
BNP Paribas Financial Markets
Redmile Group LLC
EntryPoint Capital LLC
California State Teachers Retirement System
Principal Financial Group Inc.
Walleye Trading LLC
In the last year, company insiders that have sold Replimune Group company stock include:
Robert Coffin (Director)
Philip Astley-Sparke (CEO)
Philip Astley-Sparke (Chairman)
Colin Love (COO)
Pamela Esposito (Insider)
Sushil Patel (CEO)
Sushil Patel (Insider)
Tanya Lewis (Insider)
Learn More investors selling Replimune Group stock.
Which institutional investors are buying Replimune Group stock?: Within the previous quarter, REPL stock was acquired by institutional investors including:
Price T Rowe Associates Inc. MD
Jacobs Levy Equity Management Inc.
Acadian Asset Management LLC
Denali Advisors LLC
Vanguard Group Inc.
Los Angeles Capital Management LLC
Nan Fung Group Holdings Ltd
SG Americas Securities LLC